| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO and Chairman of the Board
1 company
Mark Weinreb last filed a Form 4 in September 2019, as CEO and Chairman of the Board at BRTX. Mark Weinreb's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 117,000 shares of BRTX. Net of sales, the BRTX filings show accumulation of 37,000 shares.
Mark Weinreb has 9 Form 4 filings on record from December 2015 to September 2019, all as CEO and Chairman of the Board at BioRestorative Therapies (BRTX), 2015–2019.
The 51 reported transactions were 21 option or other derivative awards, 17 dispositions back to the company, 11 open-market purchases and 2 gifts.
Counted by filing, the open-market trades come to 3 purchases worth about $9K and no sales.
The largest open-market purchase was 22,000 shares of BRTX at an average $0.25 on September 6, 2019, about $6K.
Shares as reported in the last Form 4 for each company; the most recent is from September 2019. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 6, 2019 | BRTX Biorestorative Therapies, Inc. | CEO and Chairman of the Board | Buy | 22,000 | $0.25 | $5,530.25 | +23.2% | |
| Aug 29, 2019 | BRTX Biorestorative Therapies, Inc. | CEO and Chairman of the Board | Buy | 10,000 | $0.26 | $2,607.50 | +11.8% | |
| Aug 22, 2019 | BRTX Biorestorative Therapies, Inc. | CEO and Chairman of the Board | Buy | 5,000 | $0.26 | $1,312.30 | +6.3% |